Synbiozymes’ Post

Forbion is pleased to announce its second BioEconomy fund investment in just two days, co-leading an oversubscribed €17.4m Series A financing round for NOVAMEAT, alongside Sofinnova Partners and existing investors Unovis Asset Management, Praesidium and Rubio Impact Ventures. This funding will enable Novameat to scale its production capacity through its proprietary MicroForce technology, further driving the development of sustainable plant-based meat alternatives. Alexander Hoffmann, General Partner at Forbion, will join the Novameat Board of Directors, while Joy Faucher, Partner at Forbion, will be appointed as Board Observer. This investment underscores our commitment to advancing biotech innovations that address urgent planetary health challenges. #VentureCapital #Impact #SustainableInnovation #BioEconomy #PlantBased #FutureOfFood #PlanetaryHealth #ESG #VC #lifesciences #biotech Click on the following link to read more: https://lnkd.in/ebAZw3XS

🌱 Shaping the future of food with plant-based innovation! 🌍 Forbion via its BioEconomy fund strategy, co-led the €17.4M oversubscribed Series A for Novameat alongside Sofinnova Partners 🚀 🍔 What sets NOVAMEAT apart? Their proprietary technology enables clean-label, plant-based meat with no artificial additives, delivering a sustainable, high-quality product that meets the growing demand for healthier and eco-friendly alternatives. By focusing on B2B, they’re empowering food producers globally to create plant-based options without compromising on flavor or texture. 👥 Huge congrats to founder Giuseppe Scionti for pioneering this game-changing innovation, and to our co-investors, including existing backers Unovis Asset Management, Praesidium and Rubio Impact Ventures! 👏 Shoutout to Joy Faucher and Alexander Hoffmann from the Forbion BioEconomy team for leading this deal. We’re proud to back biotech innovations like Novameat that are transforming the food industry and helping create a more sustainable future. 💡 We’re continuing to raise our fund—let’s connect if you want to learn more! #Sustainability #PlantBased #Biotech #Impact #FoodTech #Innovation #CleanLabel #B2B #SeriesA #FutureOfFood

Did you know that ~61% of European farmers have adopted or are planning to adopt AgTech innovations within the next 2 years? This week, we analysed 62 European AgTech players and gathered insights from industry executives on how rising food consumption needs and increased technological intensity in agricultural processes are set to drive demand for AgTech. PE-led interest has been high, with ~55% of identified assets being sponsor-backed. Herein, long-term growth prospects, sustainability trends and farming unit economics represent key factors attracting financial sponsors. On the other hand, fast-changing regulatory frameworks and the delayed pace of investments by farmers act as detractors for investors. AgFunder, Astanor Ventures, Azimut Group, Alexandria Real Estate Equities, Inc., Balderton Capital, Capagro, BNP Paribas Développement, BNP Paribas Fortis Private Banking & Wealth Management, Breega, Caisse de dépôt et placement du Québec (CDPQ), Casdin Capital, LLC, Cherry Ventures, Demeter, European Circular Bioeconomy Fund (ECBF), Flexstone Partners, Founders Future, Gimv, Index Ventures, Innovation Industries, Kima Ventures, Lightrock, M CAPITAL, Multicroissance, Mirova, NCI, Pymwymic, Qbic Fund | Venture Capital, Qatar Investment Authority, Rabo Investments, RTP Global, S2G Ventures, Sofinnova Partners, Sofiprotéol, Tikehau Capital, TriplePoint Capital, Turenne Groupe, Unigrains, United Ventures, Verve Ventures and XAnge are currently invested in the European AgTech market. Interested? Read our full report: https://lnkd.in/gqpSzjWX #origination #privateequity #fintech #agriculture #agtech #technology #foodproduction #automation

🔬 𝐃𝐫𝐢𝐯𝐢𝐧𝐠 𝐢𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐞𝐱𝐩𝐚𝐧𝐬𝐢𝐨𝐧 𝐨𝐟 𝐃𝐮𝐭𝐜𝐡 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐰𝐢𝐭𝐡 𝐢𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐢𝐧 𝐅𝐨𝐫𝐛𝐢𝐨𝐧’𝐬 𝐧𝐞𝐰 𝐟𝐮𝐧𝐝 We’re proud to announce that Invest International is investing €10 million in Forbion's BioEconomy Fund, a cutting-edge fund that focuses on sustainable biotechnology in food and materials that work to improve the health of the planet. Our commitment ensures a strong Dutch biotech presence in Europe, helping Dutch companies scale proven technologies beyond the Netherlands. About Forbion’s BioEconomy Fund: Forbion is a frontrunner in European biotech. With its bioeconomy fund, Forbion is expanding its focus investing in innovative biotech in the subsectors food and sustainable materials. This includes groundbreaking technologies such as biopesticides and plastic-eating enzymes. By backing startups with proven technologies ready to scale, Forbion is driving transformative solutions across Europe and the US. Also joining the fund is Invest-NL, contributing €7.5 million to driving domestic innovations within the Netherlands. We thank our colleagues at Invest-NL for the good cooperation on this investment. Why this matters: 🌾 Supporting our focus on key sectors like Agri-Food and Sustainable Manufacturing, where Dutch expertise can help transform food systems, reduce waste, and advance circular economies. 🌍 Strengthening international ventures, helping innovative Dutch businesses access markets beyond the Netherlands and scale up their impact. 🤝 Attracting further interest from impact investors, showcasing how collaboration in financing can accelerate sustainable development. #bioeconomy #sustainableinvesting #dutchinnovation 

Loop Biotech has found its match for you to join us as a shareholder! 🚀 Say hello to Invesdor Benelux – our chosen investor platform. Why did we choose Invesdor (formerly OnePlanetCrowd)? 🏆 Largest impacting investing platform in Europe with over 180K loyal members. 🇪🇺With Invesdor everyone in Europe is able to invest in Loop Biotech. ✅ It is a user-friendly platform that is simple and safe. 🌱 Just like our mission, their community has a big focus on sustainability. This is your final reminder to pre-register before the deadline (23:59 March 12). Click on the link in the comments and register now! ☠️ Keep you posted! 👀 #investment #invesdor #greentech #loopbiotech #gogreen Invesdor Nordics Invesdor DACH Let’s go: Maarten de Jong, Peter Vriesman, Marianne Bakker, Jan-Eric Müller 💥

To celebrate closing 50 deals, today we spotlight Verqor Verqor is on a mission to digitize the agriculture sector in Latin America with smallholder farmers at their core. Only 10% of farmers in Mexico have access to formal financing options, and Verqor’s credit analysis process is aiming to change this. By providing cashless credit, inputs, and other agricultural services to farmers in Mexico. And facilitating connectivity across key industry players from input manufacturers to farmers to buyers. “MCV is a fund that embodies the concept of smart money and impact investment, with a very clear vision of generating a positive impact on people and the environment.”- Hugo Garduño Ortega, Social Entrepreneur & CEO at Verqor #ClimateResilience #SustainableAgriculture #AgTech #FinTech #Latam

Attending #Bio Europe Spring again after some years has been inspiring. As former executive of a #Biotech company who now works as consultant for such companies, I enjoy learning about how much the Biotech environment has changed in #Europe and especially in #Spain. Six Spanish #Venturecapital entities organizing a joint together between companies and investors in globally is something that was a dream when I joined the sector in 2008. All of them are to be mentioned: Caixa Capital Risc, Asabys Partners, Invivo Partners, Ysios Capital, COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U. and Aliath Bioventures I had the possibility to listen to many intriguing presentations from a wide range of perspectives: my friend Jose Mesa from COLUMBUS VENTURE PARTNERS,Sc.G.E.I.C., S.A.U. talked about their social view translated into the Fundación Columbus for treating children with #rarediseases. Clara Campàs Moya from Asabys Partners explained their investment strategy and how the impact of investments are measured from an #ESG perspective. Laura A. Lane from Eli Lilly and Company provided colour on their three-pilar strategy for investment and Alain Huriez Hureiz from AdBio partners gave his view as a foreign #VentureCapital investing in Spain. Lubor Gaal and Philippe Lopes-Fernandes gave concise advice, stating “Do not do it because of fashion” or “If you want to codevelop with pharma companies, have clear goals for such a cooperation or you will fail.” What does the future of #Biotech hold? I don’t know, but I leave this conference with new ideas and a sense of excitement for what is to come. 

Decarb Connect - Decarb TechInvest event is less than 7 weeks away! Taking place in Boston, September 10th-11th, the event is unlike any other climate event and focuses on facilitating investments across the full capital stack to de-risk, scale and exit essential hardtech and startups at Series B+ and FOAK phase, to accelerate the commercialization of breakthrough technologies.   Our CEO, Martin Keighley be speaking on the panel; ‘When rubber hits the road: Raising Capital for FOAK projects – what strategies are you using to get FOAK funding or support?’ alongside Trevor Best, Leah Ellis, Shashank Samala and Kerri Fox. Click here to download the agenda and book online: https://hubs.li/Q02GW57R0 #decarbconnect #DCTI24 #decarbtechinvest #decarbonization #decarbtech #hardtech #climatetech #industrialemitter #carbon #carbonemissions #ccus #ccu #carboncapture #netzero #netzerotech #foak #firstofakind #energytech #wasteheat #syntheticbiology #longdurationenergystorage #CarbonFree #raisingcapital #strategy

The question of whether or not to work with a CMO is one we have helped many of our clients answer, and it is one that has serious implications for determining a startup's success in scaling their technology. Join John Ellersick P.E. PMP tomorrow as he shares our insights from the field in this webinar collaboration with BioP2P Network! We invite all those who are interested in this topic, including current CMO facility owners and/or those who are considering becoming CMO facility owners/operators. Spread the word! Link below, thanks again to BioP2P Network for the opportunity to share. https://lnkd.in/e7Abag5R #scaleup #climatetech #CMO #bioeconomy

Icos Capital is thrilled to join MOA foodtech on their continued development journey. Recently, we had the opportunity to ask Bosco Emparanza García, CEO and Co-Founder of MOA, about the next steps following the successful closing of the financial round with ICOS Capital. Questions: 1. What is unique about MOA? 2. In which stage of development is MOA now? 3. ⁠How do you make sure that your technology is hyper scalable? 4. ⁠How will the secured funds be used? #scaleup #development #hyperscalable #industrybiotech #fermentation #functional #ingredients